nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—MAP2K5—restless legs syndrome	0.824	1	CbGaD
Dasatinib—SIK1—Circadian rythm related genes—BTBD9—restless legs syndrome	0.00389	0.0601	CbGpPWpGaD
Dasatinib—BMPR1B—peripheral nervous system—restless legs syndrome	0.00365	0.0329	CbGeAlD
Dasatinib—MAP3K2—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.00279	0.0432	CbGpPWpGaD
Dasatinib—ERBB3—peripheral nervous system—restless legs syndrome	0.00274	0.0247	CbGeAlD
Dasatinib—EPHB1—EPHB forward signaling—TF—restless legs syndrome	0.00261	0.0403	CbGpPWpGaD
Dasatinib—EPHB3—nerve—restless legs syndrome	0.00258	0.0232	CbGeAlD
Dasatinib—MAP3K3—peripheral nervous system—restless legs syndrome	0.00231	0.0208	CbGeAlD
Dasatinib—PTK6—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00216	0.0334	CbGpPWpGaD
Dasatinib—EPHA4—nerve—restless legs syndrome	0.00215	0.0194	CbGeAlD
Dasatinib—ZAK—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.0021	0.0325	CbGpPWpGaD
Dasatinib—MYT1—spinal cord—restless legs syndrome	0.00191	0.0172	CbGeAlD
Dasatinib—PTK6—Focal Adhesion—MAP2K5—restless legs syndrome	0.0019	0.0294	CbGpPWpGaD
Dasatinib—EPHB3—EPHB forward signaling—TF—restless legs syndrome	0.00176	0.0272	CbGpPWpGaD
Dasatinib—EPHB2—brainstem—restless legs syndrome	0.00168	0.0151	CbGeAlD
Dasatinib—MYT1—nervous system—restless legs syndrome	0.00161	0.0145	CbGeAlD
Dasatinib—MYT1—central nervous system—restless legs syndrome	0.00155	0.0139	CbGeAlD
Dasatinib—STAT5B—brainstem—restless legs syndrome	0.00152	0.0137	CbGeAlD
Dasatinib—MAP4K5—Insulin Signaling—MAP2K5—restless legs syndrome	0.00151	0.0234	CbGpPWpGaD
Dasatinib—EPHB4—EPHB forward signaling—TF—restless legs syndrome	0.0015	0.0232	CbGpPWpGaD
Dasatinib—EPHB2—EPHB forward signaling—TF—restless legs syndrome	0.00145	0.0224	CbGpPWpGaD
Dasatinib—SRMS—Focal Adhesion—MAP2K5—restless legs syndrome	0.00132	0.0204	CbGpPWpGaD
Dasatinib—TNK2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00124	0.0192	CbGpPWpGaD
Dasatinib—MYT1—brain—restless legs syndrome	0.00123	0.0111	CbGeAlD
Dasatinib—CSK—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.00118	0.0182	CbGpPWpGaD
Dasatinib—MAP3K2—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.00113	0.0175	CbGpPWpGaD
Dasatinib—CSF1R—Differentiation Pathway—TF—restless legs syndrome	0.00113	0.0175	CbGpPWpGaD
Dasatinib—TXK—Focal Adhesion—MAP2K5—restless legs syndrome	0.00112	0.0174	CbGpPWpGaD
Dasatinib—EPHB3—brainstem—restless legs syndrome	0.00111	0.00998	CbGeAlD
Dasatinib—MAPK14—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.0011	0.0171	CbGpPWpGaD
Dasatinib—TNK2—Focal Adhesion—MAP2K5—restless legs syndrome	0.00109	0.0169	CbGpPWpGaD
Dasatinib—EPHB1—nervous system—restless legs syndrome	0.00107	0.00966	CbGeAlD
Dasatinib—STK35—brainstem—restless legs syndrome	0.00104	0.00935	CbGeAlD
Dasatinib—EPHB1—central nervous system—restless legs syndrome	0.00103	0.0093	CbGeAlD
Dasatinib—SIK2—nervous system—restless legs syndrome	0.000947	0.00853	CbGeAlD
Dasatinib—EPHA4—brainstem—restless legs syndrome	0.000925	0.00833	CbGeAlD
Dasatinib—PKMYT1—nervous system—restless legs syndrome	0.000922	0.00831	CbGeAlD
Dasatinib—SIK2—central nervous system—restless legs syndrome	0.000911	0.00821	CbGeAlD
Dasatinib—LIMK2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000898	0.0139	CbGpPWpGaD
Dasatinib—PKMYT1—central nervous system—restless legs syndrome	0.000888	0.008	CbGeAlD
Dasatinib—EPHB2—nervous system—restless legs syndrome	0.00088	0.00793	CbGeAlD
Dasatinib—ERBB3—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00088	0.0136	CbGpPWpGaD
Dasatinib—MAP3K2—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.00088	0.0136	CbGpPWpGaD
Dasatinib—SRMS—nervous system—restless legs syndrome	0.000861	0.00776	CbGeAlD
Dasatinib—MAPK14—brainstem—restless legs syndrome	0.000853	0.00768	CbGeAlD
Dasatinib—STAT5B—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000852	0.0132	CbGpPWpGaD
Dasatinib—EPHB2—central nervous system—restless legs syndrome	0.000847	0.00763	CbGeAlD
Dasatinib—EPHA8—nervous system—restless legs syndrome	0.000844	0.0076	CbGeAlD
Dasatinib—SRMS—central nervous system—restless legs syndrome	0.000829	0.00747	CbGeAlD
Dasatinib—EPHB1—brain—restless legs syndrome	0.000819	0.00738	CbGeAlD
Dasatinib—EPHA8—central nervous system—restless legs syndrome	0.000812	0.00732	CbGeAlD
Dasatinib—MAP3K2—Insulin Signaling—MAP2K5—restless legs syndrome	0.000808	0.0125	CbGpPWpGaD
Dasatinib—MAP3K2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.0008	0.0124	CbGpPWpGaD
Dasatinib—CSK—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.0008	0.0124	CbGpPWpGaD
Dasatinib—STAT5B—nervous system—restless legs syndrome	0.000798	0.00719	CbGeAlD
Dasatinib—FYN—brainstem—restless legs syndrome	0.000792	0.00713	CbGeAlD
Dasatinib—MAP3K2—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000777	0.012	CbGpPWpGaD
Dasatinib—STAT5B—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000775	0.012	CbGpPWpGaD
Dasatinib—EPHA5—spinal cord—restless legs syndrome	0.000775	0.00698	CbGeAlD
Dasatinib—STAT5B—central nervous system—restless legs syndrome	0.000768	0.00692	CbGeAlD
Dasatinib—BTK—spinal cord—restless legs syndrome	0.000755	0.0068	CbGeAlD
Dasatinib—MAPK14—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.000751	0.0116	CbGpPWpGaD
Dasatinib—EPHA3—nervous system—restless legs syndrome	0.000737	0.00665	CbGeAlD
Dasatinib—SIK2—brain—restless legs syndrome	0.000723	0.00652	CbGeAlD
Dasatinib—SIK3—nervous system—restless legs syndrome	0.000717	0.00646	CbGeAlD
Dasatinib—FYN—Ectoderm Differentiation—TOX3—restless legs syndrome	0.000711	0.011	CbGpPWpGaD
Dasatinib—EPHA3—central nervous system—restless legs syndrome	0.00071	0.0064	CbGeAlD
Dasatinib—PKMYT1—brain—restless legs syndrome	0.000705	0.00635	CbGeAlD
Dasatinib—TESK1—spinal cord—restless legs syndrome	0.0007	0.0063	CbGeAlD
Dasatinib—MAP3K3—Insulin Signaling—MAP2K5—restless legs syndrome	0.000695	0.0108	CbGpPWpGaD
Dasatinib—SIK3—central nervous system—restless legs syndrome	0.000691	0.00622	CbGeAlD
Dasatinib—EPHB3—spinal cord—restless legs syndrome	0.000689	0.0062	CbGeAlD
Dasatinib—MAP3K3—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000688	0.0106	CbGpPWpGaD
Dasatinib—EPHB2—brain—restless legs syndrome	0.000673	0.00606	CbGeAlD
Dasatinib—ZAK—nervous system—restless legs syndrome	0.000667	0.00601	CbGeAlD
Dasatinib—LIMK2—spinal cord—restless legs syndrome	0.000666	0.006	CbGeAlD
Dasatinib—SRMS—brain—restless legs syndrome	0.000658	0.00593	CbGeAlD
Dasatinib—PDGFRA—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000653	0.0101	CbGpPWpGaD
Dasatinib—EPHA5—nervous system—restless legs syndrome	0.000653	0.00588	CbGeAlD
Dasatinib—LYN—nervous system—restless legs syndrome	0.000649	0.00585	CbGeAlD
Dasatinib—EPHA8—brain—restless legs syndrome	0.000645	0.00581	CbGeAlD
Dasatinib—ZAK—central nervous system—restless legs syndrome	0.000642	0.00579	CbGeAlD
Dasatinib—CSK—spinal cord—restless legs syndrome	0.000641	0.00578	CbGeAlD
Dasatinib—MAP3K19—nervous system—restless legs syndrome	0.000639	0.00576	CbGeAlD
Dasatinib—BMPR1B—nervous system—restless legs syndrome	0.000639	0.00576	CbGeAlD
Dasatinib—HCK—spinal cord—restless legs syndrome	0.000633	0.0057	CbGeAlD
Dasatinib—MAP2K5—brainstem—restless legs syndrome	0.000632	0.0057	CbGeAlD
Dasatinib—EPHA5—central nervous system—restless legs syndrome	0.000628	0.00566	CbGeAlD
Dasatinib—TNK2—nervous system—restless legs syndrome	0.000627	0.00565	CbGeAlD
Dasatinib—LYN—central nervous system—restless legs syndrome	0.000625	0.00563	CbGeAlD
Dasatinib—BMPR1B—central nervous system—restless legs syndrome	0.000616	0.00555	CbGeAlD
Dasatinib—MAP3K19—central nervous system—restless legs syndrome	0.000616	0.00555	CbGeAlD
Dasatinib—STAT5B—brain—restless legs syndrome	0.00061	0.0055	CbGeAlD
Dasatinib—TNK2—central nervous system—restless legs syndrome	0.000604	0.00544	CbGeAlD
Dasatinib—RIPK2—spinal cord—restless legs syndrome	0.000595	0.00536	CbGeAlD
Dasatinib—TESK1—nervous system—restless legs syndrome	0.00059	0.00531	CbGeAlD
Dasatinib—PDGFRB—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000588	0.00909	CbGpPWpGaD
Dasatinib—SIK1—spinal cord—restless legs syndrome	0.000581	0.00523	CbGeAlD
Dasatinib—EPHB3—nervous system—restless legs syndrome	0.00058	0.00523	CbGeAlD
Dasatinib—STK36—nervous system—restless legs syndrome	0.00058	0.00523	CbGeAlD
Dasatinib—ERBB3—spinal cord—restless legs syndrome	0.000569	0.00513	CbGeAlD
Dasatinib—TESK1—central nervous system—restless legs syndrome	0.000568	0.00511	CbGeAlD
Dasatinib—KIT—Differentiation Pathway—TF—restless legs syndrome	0.000565	0.00874	CbGpPWpGaD
Dasatinib—EPHA3—brain—restless legs syndrome	0.000564	0.00508	CbGeAlD
Dasatinib—LIMK2—nervous system—restless legs syndrome	0.000561	0.00505	CbGeAlD
Dasatinib—KIT—brainstem—restless legs syndrome	0.00056	0.00505	CbGeAlD
Dasatinib—EPHB3—central nervous system—restless legs syndrome	0.000559	0.00503	CbGeAlD
Dasatinib—STK36—central nervous system—restless legs syndrome	0.000559	0.00503	CbGeAlD
Dasatinib—SIK3—brain—restless legs syndrome	0.000548	0.00494	CbGeAlD
Dasatinib—STK35—nervous system—restless legs syndrome	0.000544	0.0049	CbGeAlD
Dasatinib—HCK—Focal Adhesion—MAP2K5—restless legs syndrome	0.000541	0.00836	CbGpPWpGaD
Dasatinib—CSK—nervous system—restless legs syndrome	0.00054	0.00487	CbGeAlD
Dasatinib—LIMK2—central nervous system—restless legs syndrome	0.00054	0.00487	CbGeAlD
Dasatinib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.000535	0.00828	CbGpPWpGaD
Dasatinib—HCK—nervous system—restless legs syndrome	0.000533	0.0048	CbGeAlD
Dasatinib—MAPK14—spinal cord—restless legs syndrome	0.00053	0.00478	CbGeAlD
Dasatinib—STK35—central nervous system—restless legs syndrome	0.000523	0.00472	CbGeAlD
Dasatinib—CSK—central nervous system—restless legs syndrome	0.00052	0.00469	CbGeAlD
Dasatinib—HCK—central nervous system—restless legs syndrome	0.000513	0.00463	CbGeAlD
Dasatinib—ZAK—brain—restless legs syndrome	0.00051	0.00459	CbGeAlD
Dasatinib—EPHB4—spinal cord—restless legs syndrome	0.000503	0.00453	CbGeAlD
Dasatinib—JAK2—spinal cord—restless legs syndrome	0.000499	0.0045	CbGeAlD
Dasatinib—EPHA5—brain—restless legs syndrome	0.000499	0.0045	CbGeAlD
Dasatinib—LYN—brain—restless legs syndrome	0.000496	0.00447	CbGeAlD
Dasatinib—FYN—spinal cord—restless legs syndrome	0.000492	0.00444	CbGeAlD
Dasatinib—BLK—Focal Adhesion—MAP2K5—restless legs syndrome	0.00049	0.00758	CbGpPWpGaD
Dasatinib—SIK1—nervous system—restless legs syndrome	0.000489	0.00441	CbGeAlD
Dasatinib—BMPR1B—brain—restless legs syndrome	0.000489	0.0044	CbGeAlD
Dasatinib—MAP3K19—brain—restless legs syndrome	0.000489	0.0044	CbGeAlD
Dasatinib—FGR—Focal Adhesion—MAP2K5—restless legs syndrome	0.000488	0.00755	CbGpPWpGaD
Dasatinib—ABL1—brainstem—restless legs syndrome	0.000488	0.0044	CbGeAlD
Dasatinib—BTK—brain—restless legs syndrome	0.000486	0.00438	CbGeAlD
Dasatinib—EPHA4—nervous system—restless legs syndrome	0.000485	0.00437	CbGeAlD
Dasatinib—FYN—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000484	0.00748	CbGpPWpGaD
Dasatinib—MAP3K3—spinal cord—restless legs syndrome	0.000481	0.00433	CbGeAlD
Dasatinib—MAP4K5—spinal cord—restless legs syndrome	0.000481	0.00433	CbGeAlD
Dasatinib—ERBB3—nervous system—restless legs syndrome	0.00048	0.00432	CbGeAlD
Dasatinib—TNK2—brain—restless legs syndrome	0.000479	0.00432	CbGeAlD
Dasatinib—MAP3K2—nervous system—restless legs syndrome	0.000475	0.00428	CbGeAlD
Dasatinib—SIK1—central nervous system—restless legs syndrome	0.000471	0.00425	CbGeAlD
Dasatinib—EPHA4—central nervous system—restless legs syndrome	0.000467	0.0042	CbGeAlD
Dasatinib—ERBB3—central nervous system—restless legs syndrome	0.000462	0.00416	CbGeAlD
Dasatinib—EPHB6—spinal cord—restless legs syndrome	0.00046	0.00414	CbGeAlD
Dasatinib—MAP3K2—central nervous system—restless legs syndrome	0.000457	0.00412	CbGeAlD
Dasatinib—TESK1—brain—restless legs syndrome	0.000451	0.00406	CbGeAlD
Dasatinib—MAPK14—nervous system—restless legs syndrome	0.000447	0.00403	CbGeAlD
Dasatinib—FGR—nervous system—restless legs syndrome	0.000445	0.00401	CbGeAlD
Dasatinib—YES1—spinal cord—restless legs syndrome	0.000444	0.004	CbGeAlD
Dasatinib—STK36—brain—restless legs syndrome	0.000443	0.004	CbGeAlD
Dasatinib—EPHB3—brain—restless legs syndrome	0.000443	0.004	CbGeAlD
Dasatinib—PDGFRA—spinal cord—restless legs syndrome	0.000436	0.00393	CbGeAlD
Dasatinib—MAPK14—central nervous system—restless legs syndrome	0.00043	0.00388	CbGeAlD
Dasatinib—FMO3—nervous system—restless legs syndrome	0.00043	0.00387	CbGeAlD
Dasatinib—LIMK2—brain—restless legs syndrome	0.000429	0.00386	CbGeAlD
Dasatinib—FGR—central nervous system—restless legs syndrome	0.000428	0.00386	CbGeAlD
Dasatinib—SRC—spinal cord—restless legs syndrome	0.000427	0.00385	CbGeAlD
Dasatinib—ERBB3—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000421	0.00651	CbGpPWpGaD
Dasatinib—JAK2—nervous system—restless legs syndrome	0.000421	0.00379	CbGeAlD
Dasatinib—SRC—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000418	0.00646	CbGpPWpGaD
Dasatinib—STK35—brain—restless legs syndrome	0.000416	0.00374	CbGeAlD
Dasatinib—EPHA2—nervous system—restless legs syndrome	0.000415	0.00374	CbGeAlD
Dasatinib—FYN—nervous system—restless legs syndrome	0.000415	0.00374	CbGeAlD
Dasatinib—FYN—Syndecan-3-mediated signaling events—POMC—restless legs syndrome	0.000415	0.00641	CbGpPWpGaD
Dasatinib—FMO3—central nervous system—restless legs syndrome	0.000414	0.00373	CbGeAlD
Dasatinib—CSK—brain—restless legs syndrome	0.000413	0.00372	CbGeAlD
Dasatinib—ABCG2—Iron uptake and transport—TF—restless legs syndrome	0.000409	0.00633	CbGpPWpGaD
Dasatinib—HCK—brain—restless legs syndrome	0.000407	0.00367	CbGeAlD
Dasatinib—MAP4K5—nervous system—restless legs syndrome	0.000405	0.00365	CbGeAlD
Dasatinib—MAP3K3—nervous system—restless legs syndrome	0.000405	0.00365	CbGeAlD
Dasatinib—ABL2—brain—restless legs syndrome	0.000405	0.00365	CbGeAlD
Dasatinib—JAK2—central nervous system—restless legs syndrome	0.000405	0.00365	CbGeAlD
Dasatinib—SRC—EPHB forward signaling—TF—restless legs syndrome	0.000404	0.00625	CbGpPWpGaD
Dasatinib—EPHA2—central nervous system—restless legs syndrome	0.0004	0.0036	CbGeAlD
Dasatinib—FYN—central nervous system—restless legs syndrome	0.000399	0.0036	CbGeAlD
Dasatinib—MAP2K5—spinal cord—restless legs syndrome	0.000393	0.00354	CbGeAlD
Dasatinib—MAP4K5—central nervous system—restless legs syndrome	0.00039	0.00352	CbGeAlD
Dasatinib—MAP3K3—central nervous system—restless legs syndrome	0.00039	0.00352	CbGeAlD
Dasatinib—EPHB6—nervous system—restless legs syndrome	0.000387	0.00349	CbGeAlD
Dasatinib—CSF1R—spinal cord—restless legs syndrome	0.000384	0.00346	CbGeAlD
Dasatinib—RIPK2—brain—restless legs syndrome	0.000383	0.00345	CbGeAlD
Dasatinib—YES1—nervous system—restless legs syndrome	0.000374	0.00337	CbGeAlD
Dasatinib—SIK1—brain—restless legs syndrome	0.000374	0.00337	CbGeAlD
Dasatinib—EPHB6—central nervous system—restless legs syndrome	0.000373	0.00336	CbGeAlD
Dasatinib—EPHA4—brain—restless legs syndrome	0.00037	0.00334	CbGeAlD
Dasatinib—RIPK2—Signaling by NGF—MAP2K5—restless legs syndrome	0.000367	0.00568	CbGpPWpGaD
Dasatinib—PDGFRA—nervous system—restless legs syndrome	0.000367	0.00331	CbGeAlD
Dasatinib—ERBB3—brain—restless legs syndrome	0.000367	0.0033	CbGeAlD
Dasatinib—MAP3K2—brain—restless legs syndrome	0.000363	0.00327	CbGeAlD
Dasatinib—FYN—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000361	0.00559	CbGpPWpGaD
Dasatinib—YES1—central nervous system—restless legs syndrome	0.00036	0.00325	CbGeAlD
Dasatinib—SRC—nervous system—restless legs syndrome	0.00036	0.00325	CbGeAlD
Dasatinib—FMO3—SIDS Susceptibility Pathways—TF—restless legs syndrome	0.000357	0.00553	CbGpPWpGaD
Dasatinib—SRC—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000356	0.00551	CbGpPWpGaD
Dasatinib—PDGFRA—central nervous system—restless legs syndrome	0.000354	0.00319	CbGeAlD
Dasatinib—KIT—spinal cord—restless legs syndrome	0.000348	0.00314	CbGeAlD
Dasatinib—MAPK14—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000348	0.00538	CbGpPWpGaD
Dasatinib—SRC—central nervous system—restless legs syndrome	0.000347	0.00312	CbGeAlD
Dasatinib—JAK2—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000343	0.00531	CbGpPWpGaD
Dasatinib—SRC—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000343	0.0053	CbGpPWpGaD
Dasatinib—CYP1B1—Endogenous sterols—POMC—restless legs syndrome	0.000342	0.00528	CbGpPWpGaD
Dasatinib—MAPK14—brain—restless legs syndrome	0.000341	0.00308	CbGeAlD
Dasatinib—PDGFRB—spinal cord—restless legs syndrome	0.00034	0.00307	CbGeAlD
Dasatinib—FGR—brain—restless legs syndrome	0.00034	0.00306	CbGeAlD
Dasatinib—CSK—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000333	0.00516	CbGpPWpGaD
Dasatinib—PDGFRA—Focal Adhesion—MAP2K5—restless legs syndrome	0.000333	0.00515	CbGpPWpGaD
Dasatinib—ABL1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000332	0.00514	CbGpPWpGaD
Dasatinib—PDGFRB—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000331	0.00512	CbGpPWpGaD
Dasatinib—MAP2K5—nervous system—restless legs syndrome	0.000331	0.00299	CbGeAlD
Dasatinib—KIT—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00033	0.0051	CbGpPWpGaD
Dasatinib—STAT5B—Glucocorticoid receptor regulatory network—POMC—restless legs syndrome	0.000329	0.00508	CbGpPWpGaD
Dasatinib—FMO3—brain—restless legs syndrome	0.000328	0.00296	CbGeAlD
Dasatinib—ERBB3—Signaling by NGF—MAP2K5—restless legs syndrome	0.000324	0.00501	CbGpPWpGaD
Dasatinib—EPHB4—brain—restless legs syndrome	0.000324	0.00292	CbGeAlD
Dasatinib—CSF1R—nervous system—restless legs syndrome	0.000323	0.00291	CbGeAlD
Dasatinib—JAK2—brain—restless legs syndrome	0.000321	0.0029	CbGeAlD
Dasatinib—MAPK14—Insulin Signaling—MAP2K5—restless legs syndrome	0.00032	0.00494	CbGpPWpGaD
Dasatinib—MAP2K5—central nervous system—restless legs syndrome	0.000319	0.00287	CbGeAlD
Dasatinib—EPHA2—brain—restless legs syndrome	0.000318	0.00286	CbGeAlD
Dasatinib—FYN—brain—restless legs syndrome	0.000317	0.00286	CbGeAlD
Dasatinib—MAPK14—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000317	0.0049	CbGpPWpGaD
Dasatinib—JAK2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000312	0.00483	CbGpPWpGaD
Dasatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000312	0.00483	CbGpPWpGaD
Dasatinib—CSF1R—central nervous system—restless legs syndrome	0.000311	0.0028	CbGeAlD
Dasatinib—MAP4K5—brain—restless legs syndrome	0.00031	0.00279	CbGeAlD
Dasatinib—MAP3K3—brain—restless legs syndrome	0.00031	0.00279	CbGeAlD
Dasatinib—MAPK14—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000307	0.00475	CbGpPWpGaD
Dasatinib—SRC—Syndecan-3-mediated signaling events—POMC—restless legs syndrome	0.000306	0.00472	CbGpPWpGaD
Dasatinib—ABL1—spinal cord—restless legs syndrome	0.000303	0.00273	CbGeAlD
Dasatinib—PDGFRB—Focal Adhesion—MAP2K5—restless legs syndrome	0.0003	0.00464	CbGpPWpGaD
Dasatinib—EPHB6—brain—restless legs syndrome	0.000296	0.00267	CbGeAlD
Dasatinib—KIT—nervous system—restless legs syndrome	0.000294	0.00265	CbGeAlD
Dasatinib—ABCG2—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.00029	0.00449	CbGpPWpGaD
Dasatinib—FYN—Focal Adhesion—MAP2K5—restless legs syndrome	0.000289	0.00447	CbGpPWpGaD
Dasatinib—PDGFRB—nervous system—restless legs syndrome	0.000287	0.00258	CbGeAlD
Dasatinib—FMO3—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000287	0.00443	CbGpPWpGaD
Dasatinib—YES1—brain—restless legs syndrome	0.000286	0.00258	CbGeAlD
Dasatinib—KIT—central nervous system—restless legs syndrome	0.000283	0.00255	CbGeAlD
Dasatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000281	0.00435	CbGpPWpGaD
Dasatinib—PDGFRA—brain—restless legs syndrome	0.000281	0.00253	CbGeAlD
Dasatinib—PDGFRB—central nervous system—restless legs syndrome	0.000276	0.00249	CbGeAlD
Dasatinib—SRC—brain—restless legs syndrome	0.000275	0.00248	CbGeAlD
Dasatinib—FYN—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000271	0.00419	CbGpPWpGaD
Dasatinib—SRC—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000266	0.00412	CbGpPWpGaD
Dasatinib—MAPK14—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000261	0.00404	CbGpPWpGaD
Dasatinib—JAK2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000258	0.00399	CbGpPWpGaD
Dasatinib—ABL1—nervous system—restless legs syndrome	0.000256	0.0023	CbGeAlD
Dasatinib—KIT—Signaling by NGF—MAP2K5—restless legs syndrome	0.000254	0.00392	CbGpPWpGaD
Dasatinib—MAP2K5—brain—restless legs syndrome	0.000253	0.00228	CbGeAlD
Dasatinib—CSF1R—brain—restless legs syndrome	0.000247	0.00223	CbGeAlD
Dasatinib—ABL1—central nervous system—restless legs syndrome	0.000246	0.00222	CbGeAlD
Dasatinib—SRC—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000242	0.00375	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling by NGF—MAP2K5—restless legs syndrome	0.00024	0.00372	CbGpPWpGaD
Dasatinib—LCK—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000226	0.00349	CbGpPWpGaD
Dasatinib—KIT—brain—restless legs syndrome	0.000224	0.00202	CbGeAlD
Dasatinib—PDGFRB—brain—restless legs syndrome	0.000219	0.00198	CbGeAlD
Dasatinib—PDGFRB—Signaling by NGF—MAP2K5—restless legs syndrome	0.000216	0.00335	CbGpPWpGaD
Dasatinib—CYP1B1—nervous system—restless legs syndrome	0.000216	0.00195	CbGeAlD
Dasatinib—SRC—Focal Adhesion—MAP2K5—restless legs syndrome	0.000213	0.0033	CbGpPWpGaD
Dasatinib—FYN—Signaling by NGF—MAP2K5—restless legs syndrome	0.000209	0.00323	CbGpPWpGaD
Dasatinib—CYP1B1—central nervous system—restless legs syndrome	0.000208	0.00188	CbGeAlD
Dasatinib—MAPK14—Signaling by NGF—MAP2K5—restless legs syndrome	0.000201	0.00311	CbGpPWpGaD
Dasatinib—SRC—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.0002	0.00309	CbGpPWpGaD
Dasatinib—JAK2—Signaling by NGF—MAP2K5—restless legs syndrome	0.000198	0.00307	CbGpPWpGaD
Dasatinib—ABL1—brain—restless legs syndrome	0.000195	0.00176	CbGeAlD
Dasatinib—ABCG2—spinal cord—restless legs syndrome	0.000191	0.00172	CbGeAlD
Dasatinib—LCK—Signaling by NGF—MAP2K5—restless legs syndrome	0.000174	0.00269	CbGpPWpGaD
Dasatinib—CSK—Hemostasis—TF—restless legs syndrome	0.000172	0.00266	CbGpPWpGaD
Dasatinib—CYP1B1—brain—restless legs syndrome	0.000165	0.00149	CbGeAlD
Dasatinib—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000159	0.00245	CbGpPWpGaD
Dasatinib—ABCB1—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.000157	0.00243	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—MAP2K5—restless legs syndrome	0.000155	0.00239	CbGpPWpGaD
Dasatinib—SRC—Signaling by NGF—MAP2K5—restless legs syndrome	0.000154	0.00238	CbGpPWpGaD
Dasatinib—CYP1A1—nervous system—restless legs syndrome	0.000153	0.00138	CbGeAlD
Dasatinib—FMO3—Biological oxidations—POMC—restless legs syndrome	0.000152	0.00235	CbGpPWpGaD
Dasatinib—CYP1A1—central nervous system—restless legs syndrome	0.000147	0.00133	CbGeAlD
Dasatinib—LYN—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000139	0.00215	CbGpPWpGaD
Dasatinib—FYN—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000137	0.00212	CbGpPWpGaD
Dasatinib—MAPK14—Glucocorticoid receptor regulatory network—POMC—restless legs syndrome	0.000134	0.00208	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.000133	0.00206	CbGpPWpGaD
Dasatinib—MAPK14—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000132	0.00204	CbGpPWpGaD
Dasatinib—JAK2—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00013	0.00201	CbGpPWpGaD
Dasatinib—CYP1B1—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000129	0.00199	CbGpPWpGaD
Dasatinib—ABCG2—brain—restless legs syndrome	0.000123	0.00111	CbGeAlD
Dasatinib—MAPK14—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.000122	0.00189	CbGpPWpGaD
Dasatinib—FGR—Hemostasis—TF—restless legs syndrome	0.000119	0.00184	CbGpPWpGaD
Dasatinib—CYP1A1—brain—restless legs syndrome	0.000117	0.00105	CbGeAlD
Dasatinib—LCK—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000114	0.00176	CbGpPWpGaD
Dasatinib—CYP3A4—nervous system—restless legs syndrome	0.000112	0.00101	CbGeAlD
Dasatinib—CSK—Signaling Pathways—MAP2K5—restless legs syndrome	0.000109	0.00169	CbGpPWpGaD
Dasatinib—CYP3A4—central nervous system—restless legs syndrome	0.000108	0.000974	CbGeAlD
Dasatinib—STAT5B—Signaling Pathways—MAP2K5—restless legs syndrome	0.000106	0.00163	CbGpPWpGaD
Dasatinib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000103	0.0016	CbGpPWpGaD
Dasatinib—SRC—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000101	0.00156	CbGpPWpGaD
Dasatinib—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	9.77e-05	0.00151	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—TF—restless legs syndrome	9.61e-05	0.00149	CbGpPWpGaD
Dasatinib—ABCB1—spinal cord—restless legs syndrome	9.43e-05	0.00085	CbGeAlD
Dasatinib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	8.38e-05	0.0013	CbGpPWpGaD
Dasatinib—ABCB1—nervous system—restless legs syndrome	7.95e-05	0.000716	CbGeAlD
Dasatinib—CYP1A1—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	7.92e-05	0.00122	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—MAP2K5—restless legs syndrome	7.89e-05	0.00122	CbGpPWpGaD
Dasatinib—ABCB1—central nervous system—restless legs syndrome	7.65e-05	0.000689	CbGeAlD
Dasatinib—ABCB1—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	7.2e-05	0.00111	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—TF—restless legs syndrome	7.17e-05	0.00111	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—TF—restless legs syndrome	7.14e-05	0.0011	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—TF—restless legs syndrome	7.06e-05	0.00109	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MAP2K5—restless legs syndrome	6.95e-05	0.00108	CbGpPWpGaD
Dasatinib—CYP1B1—Biological oxidations—POMC—restless legs syndrome	6.83e-05	0.00106	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—TF—restless legs syndrome	6.8e-05	0.00105	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—TF—restless legs syndrome	6.71e-05	0.00104	CbGpPWpGaD
Dasatinib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	6.23e-05	0.000963	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MAP2K5—restless legs syndrome	6.1e-05	0.000944	CbGpPWpGaD
Dasatinib—ABCB1—brain—restless legs syndrome	6.07e-05	0.000547	CbGeAlD
Dasatinib—LCK—Hemostasis—TF—restless legs syndrome	5.88e-05	0.000909	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MAP2K5—restless legs syndrome	5.45e-05	0.000843	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—TF—restless legs syndrome	5.2e-05	0.000804	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MAP2K5—restless legs syndrome	5.16e-05	0.000798	CbGpPWpGaD
Dasatinib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	5.05e-05	0.000781	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—TF—restless legs syndrome	4.93e-05	0.000762	CbGpPWpGaD
Dasatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	4.81e-05	0.000744	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MAP2K5—restless legs syndrome	4.65e-05	0.000719	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MAP2K5—restless legs syndrome	4.55e-05	0.000704	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MAP2K5—restless legs syndrome	4.48e-05	0.000693	CbGpPWpGaD
Dasatinib—CYP3A5—Biological oxidations—POMC—restless legs syndrome	4.45e-05	0.000689	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MAP2K5—restless legs syndrome	4.31e-05	0.000667	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MAP2K5—restless legs syndrome	4.26e-05	0.000659	CbGpPWpGaD
Dasatinib—CYP1A1—Biological oxidations—POMC—restless legs syndrome	4.21e-05	0.000651	CbGpPWpGaD
Dasatinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	3.9e-05	0.000603	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—POMC—restless legs syndrome	3.81e-05	0.000589	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MAP2K5—restless legs syndrome	3.73e-05	0.000577	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MAP2K5—restless legs syndrome	3.3e-05	0.000511	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—POMC—restless legs syndrome	2.68e-05	0.000415	CbGpPWpGaD
Dasatinib—CYP1A2—Biological oxidations—POMC—restless legs syndrome	2.68e-05	0.000415	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—TF—restless legs syndrome	2.66e-05	0.000412	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	2.62e-05	0.000406	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—POMC—restless legs syndrome	2.6e-05	0.000403	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—POMC—restless legs syndrome	2.6e-05	0.000402	CbGpPWpGaD
Dasatinib—CYP3A4—Biological oxidations—POMC—restless legs syndrome	2.07e-05	0.00032	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—POMC—restless legs syndrome	1.95e-05	0.000302	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—POMC—restless legs syndrome	1.94e-05	0.0003	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—POMC—restless legs syndrome	1.77e-05	0.000274	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—POMC—restless legs syndrome	1.77e-05	0.000274	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—POMC—restless legs syndrome	1.71e-05	0.000264	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	1.62e-05	0.00025	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—POMC—restless legs syndrome	1.5e-05	0.000232	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—POMC—restless legs syndrome	1.34e-05	0.000207	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—POMC—restless legs syndrome	1.27e-05	0.000196	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—POMC—restless legs syndrome	1.17e-05	0.000181	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—POMC—restless legs syndrome	1.14e-05	0.000177	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—POMC—restless legs syndrome	1.12e-05	0.000173	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—POMC—restless legs syndrome	1.1e-05	0.00017	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—POMC—restless legs syndrome	1.06e-05	0.000164	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—POMC—restless legs syndrome	1.06e-05	0.000164	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—POMC—restless legs syndrome	1.05e-05	0.000162	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	1.03e-05	0.000159	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—POMC—restless legs syndrome	9.18e-06	0.000142	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—POMC—restless legs syndrome	8.12e-06	0.000126	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—POMC—restless legs syndrome	7.62e-06	0.000118	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—POMC—restless legs syndrome	7.2e-06	0.000111	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—POMC—restless legs syndrome	5.75e-06	8.89e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—POMC—restless legs syndrome	4.59e-06	7.1e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—POMC—restless legs syndrome	3.54e-06	5.48e-05	CbGpPWpGaD
